Colorectal cancer remains one of the most common and preventable forms of cancer in the United States, yet it continues to claim tens of thousands of lives each year. The contrast between its preventability and its prevalence is largely attributable to gaps in screening compliance. Dr. Michelle Pearlman, a board-certified gastroenterologist at PRIME Institute, performs screening colonoscopies as one of the most effective preventive measures for protecting digestive health and reducing the risk of colorectal cancer. A screening colonoscopy is one of the most effective tools available in modern preventive medicine, capable of detecting precancerous polyps before they have the opportunity to develop into malignancy. For residents of Miami and the greater South Florida region, understanding when to begin screening, what the procedure involves, and how it contributes to long-term health is a matter of meaningful consequence. At PRIME Institute, Dr. Pearlman is committed to delivering thorough, patient-centered colonoscopy services that prioritize both clinical precision and patient comfort. 

What Is a Screening Colonoscopy

A screening colonoscopy is a diagnostic procedure in which Dr. Pearlman uses a long, flexible, camera-equipped instrument called a colonoscope to examine the interior lining of the large intestine, or colon. The procedure allows Dr.Pearlman to identify and, in many cases, remove abnormal growths known as polyps. While not all polyps are cancerous, certain types, particularly adenomatous polyps, have the potential to develop into colorectal cancer over a period of years if left untreated.

The procedure is typically performed under sedation, which means the patient remains comfortable and unaware during the examination. It generally takes between 20 and 40 minutes, depending on whether polyps are found and removed. The preparation process, which involves clearing the colon with a prescribed laxative solution the day before the procedure, is often described by patients as the most challenging aspect of the experience.

The American Cancer Society updated its screening guidelines in 2018, recommending that individuals at average risk begin screening at age 45 rather than the previously recommended age of 50. This change was prompted by a concerning increase in colorectal cancer diagnoses among younger adults. A 2020 study published in the Journal of the National Cancer Institute confirmed a rising incidence of early-onset colorectal cancer, particularly among adults aged 20 to 49 (Siegel et al., Journal of the National Cancer Institute, 2020). These findings underscore the importance of timely screening.

Common Patient Concerns and Indications

Many patients delay or avoid colonoscopy screening due to anxiety about the procedure, discomfort with the preparation process, or a belief that screening is unnecessary in the absence of symptoms. Each of these concerns deserves thoughtful acknowledgment and clinical perspective.

The preparation process, while admittedly inconvenient, has improved considerably in recent years. Split-dose regimens, in which the preparation solution is divided between the evening before and the morning of the procedure, have been shown to improve both patient tolerance and the quality of the colonic preparation, which in turn improves the accuracy of the examination.

Regarding the procedure itself, modern sedation techniques ensure that patients experience minimal to no discomfort. Most patients report that the anticipation of the procedure was far more challenging than the procedure itself. Recovery is generally brief, with most individuals returning to normal activities the following day.

The misconception that screening is unnecessary without symptoms is perhaps the most dangerous barrier to preventive care. Colorectal cancer often develops without any noticeable symptoms in its early stages. By the time symptoms such as changes in bowel habits, rectal bleeding, or unexplained weight loss appear, the disease may have progressed to a more advanced stage. Screening colonoscopy is specifically designed to detect precancerous changes before symptoms develop, making it a proactive rather than reactive measure.

Patients with a family history of colorectal cancer or polyps, a personal history of inflammatory bowel disease, or certain genetic syndromes may require earlier or more frequent screening. PRIME Institute evaluates each patient’s risk profile to determine the appropriate screening schedule.

How the Procedure Is Performed and How Care Is Customized

At PRIME Institute, Dr. Pearlman carefully guides patients through every stage of the colonoscopy process, ensuring safety, thoroughness, and comfort. The process begins with a preoperative consultation during which Dr. Pearlman reviews the patient’s medical history, discusses any medications that may need to be adjusted prior to the procedure, and provides detailed instructions for bowel preparation.

On the day of the procedure, the patient arrives at the facility and is prepared for sedation by the nursing team. An intravenous line is established, and the patient is positioned comfortably on an examination table. Once sedation has been administered, the colonoscope is gently advanced through the rectum and along the length of the colon. The camera transmits a real-time image to a monitor, allowing Dr. Pearlman to examine the colonic lining in detail.

If polyps are identified during the examination, Dr. Pearlman typically removed during the same procedure using specialized instruments passed through the colonoscope. This process, known as polypectomy, is painless and adds only a brief amount of time to the procedure. The removed tissue is then sent to a pathology laboratory for microscopic analysis to determine whether it contains precancerous or cancerous cells.

Dr. Pearlman tailors each examination to the patient’s anatomy and risk factors. Patients with complex medical histories, prior abdominal surgeries, or anatomical variations may require additional care and attention during the procedure. The clinical team communicates clearly with each patient before and after the examination to ensure that all questions are addressed and that the patient understands the findings and any recommended follow-up.

What Patients Can Expect After the Procedure

Following the colonoscopy, patients are monitored in a recovery area until the effects of sedation have diminished sufficiently for safe discharge. This typically takes between 30 minutes and one hour. Because sedation impairs judgment and reaction time for the remainder of the day, patients are required to arrange for a companion to drive them home after the procedure.

Mild bloating or gas is common in the hours following the procedure, as air is introduced into the colon during the examination to improve visualization. These symptoms resolve quickly and are not a cause for concern. Patients are generally advised to consume a light meal after the procedure and to resume their normal diet the following day.

If polyps were removed, the pathology results are typically available within one to two weeks. Dr. Pearlman reviews the results with the patient and provides recommendations for the timing of the next colonoscopy. For patients with no polyps, repeat screening is generally recommended in ten years. For those with certain types or numbers of polyps, the interval may be shortened to three to five years.

A 2019 study published in the New England Journal of Medicine demonstrated that colonoscopy with polypectomy reduced the long-term risk of colorectal cancer mortality by approximately 53 percent (Shaukat et al., New England Journal of Medicine, 2019). This finding reinforces the life-saving potential of the procedure.

Who Should Undergo Screening

The current guidelines from the American Cancer Society recommend that all adults at average risk begin colorectal cancer screening at age 45. For individuals with elevated risk factors, screening may begin earlier and occur at shorter intervals.

Risk factors that may warrant earlier screening include a first-degree relative diagnosed with colorectal cancer before age 60, a personal history of adenomatous polyps, inflammatory bowel disease such as ulcerative colitis or Crohn disease, and certain hereditary conditions including Lynch syndrome and familial adenomatous polyposis.

Individuals who have not undergone screening by the recommended age should not delay further. Colorectal cancer is highly treatable when detected early, and screening remains the most reliable means of early detection.

Patients who are uncertain about their risk level or screening schedule are encouraged to consult Dr. Michelle Pearlman, who can evaluate their individual circumstances. At PRIME Institute in Miami, the team takes a personalized approach to preventive care, helping each patient understand the role that screening plays in maintaining long-term health.

Scheduling a Screening Colonoscopy at PRIME Institute

Taking the step to schedule a screening colonoscopy is one of the most impactful decisions a person can make for their long-term health. The procedure is brief, well-tolerated, and supported by decades of clinical evidence demonstrating its effectiveness in preventing colorectal cancer. At PRIME Institute in Miami, patients receive care in a setting that values thoroughness, transparency, and respect for each individual’s concerns and comfort.

For residents of Miami, Coral Gables, and the surrounding communities who are due for a screening colonoscopy or who have questions about their colorectal cancer risk, PRIME Institute welcomes the opportunity to provide guidance. Patients may contact the practice through the website at primeinstitute.us or call the office directly to schedule an appointment with a member of the clinical team.